There were significant decreases in Cu/Zn SOD and CAT activities in the SLE patients, both in SLEDAI < 6 and SLEDAI ≥ 6 groups, compared to the controls (p < 0.05). This evidence concerns the gene CAT and systemic lupus erythematosus.